1Schnall MD, Blume J, Bluemke DA, et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study[ J]. Radiology ,2006,238:42.
2Reston VA. BI -PADS Atlas (4thed) [ M]. Chigago:American College of Radiology,2003. 196 - 198.
3Kuhl CK, Mielcarek P, Klaschik S, et al. Are signal time course data useful for differential diagnosis of enhancing lesions in dynamic breast MR imaging[ J]. Radiology, 1999,211 ( 1 ): 101.
5Narisada H, Aoki T, Sasagufi T, et al. Correlation between numeric gadolinium- enhanced dyn - amic MRI ratios and prognostic factors and histologic type of breast carcinoma[ J]. AJR, 2006,187:297 3O6.
6Kuhl C. The current status of breast MR imging[J]. Radiology,2007, 244 : 356 - 378.
2Castillo M, Kwock L, Mukherji SK, et al. Clinical applications of proton MR spectroscopy[J]. AJNR, 1996, 17(1) :1 - 15.
3Kvisted KA, Rydland J, Vainio J, et al. Breast lesion: evaluation with dynamic contrast - enhanced TI - weight MR imaging and with T2^* - weighted first pass perfusion MR imaging [ J ]. Radiology, 2000, 216(2) :545 -553.
4Kuhl CK, Mielcareck P, Klaschik S,et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? [ J ]. Radiology, 1999, 211 ( 1 ) : 101 - 110.
5Barrella L, Morris EA, Dershaw DD, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study [ J ]. Radiology, 2006, 239(3) : 686 -692.
6Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer[ J ]. Radiology, 2001,220 ( 1 ) : 13 -30.
7Kuhl CK. MRI of breast tumours [ J ]. Eur Radiol,2000,10 ( 1 ) :46 - 58.
8Orel SG. MR imaging of the breast[ J]. Radiol Clin North Am,2000, 38(7) :899 -913.
9Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast enhanced in vivo proton MR spectroscopy - initial results [ J ]. Radiology, 2001,220 ( 1 ) :40 - 46.
10Glunde K, Jie C, Bhujwallal ZM. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer [ J ]. Cancer Res, 2004,64 ( 12 ) :4270 - 4276.
4Lkeda DM, Baker DR, Daniel BL. Magnetic resonance ima ging of bmast cancer: clinical Indications and breast CE-MRI reporting system [J]. J Magn Reson Imaging, 2000, 12: 975- 983.
